期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

结直肠间质瘤诊治进展 被引量：5

下载PDF
导出
摘要 胃肠间质瘤(gastrointestinal stromal tumor,GIST)是一组发生于胃肠道最常见的间叶源性肿瘤。它起源于胃肠道间质干细胞---Cajal细胞(intestinal cell of cajal,ICC)或向cajal细胞分化,由梭形细胞、上皮样细胞或多形性细胞呈束状或弥漫性排列组成。目前其新的诊断定义是:一组独立起源于胃肠道间质干细胞的肿瘤,实质上由未分化或多能的梭形或上皮样细胞组成,
作者 杨朝纲 综述 熊斌 审校
机构地区 武汉大学中南医院
出处 《实用癌症杂志》 2015年第10期1575-1577,共3页 The Practical Journal of Cancer
关键词 胃肠间质瘤 结肠 外科治疗 伊马替尼
分类号 R735 [医药卫生—肿瘤]
  • 相关文献

参考文献14

  • 1Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial[J]. The Lancet . 2012
  • 2J. Li,J.F. Gong,A.W. Wu,L. Shen.Post-operative imatinib in patients with intermediate or high risk gastrointestinal stromal tumor[J]. European Journal of Surgical Oncology . 2011 (4)
  • 3Downsizing Treatment with Tyrosine Kinase Inhibitors in Patients with Advanced Gastrointestinal Stromal Tumors Improved Resectability[J]. World Journal of Surgery . 2010 (9)
  • 4Ronald P DeMatteo,Karla V Ballman,Cristina R Antonescu,Robert G Maki,Peter WT Pisters,George D Demetri,Martin E Blackstein,Charles D Blanke,Margaret von Mehren,Murray F Brennan,Shreyaskumar Patel,Martin D McCarter,Jonathan A Polikoff,Benjamin R Tan,Kouros Owzar.Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial[J]. The Lancet . 2009 (9669)
  • 5Bernadette Liegl,Jason L. Hornick,Cristina R. Antonescu,Christopher L. Corless,Christopher D. M. Fletcher.Rhabdomyosarcomatous Differentiation in Gastrointestinal Stromal Tumors After Tyrosine Kinase Inhibitor Therapy: A Novel Form of Tumor Progression[J]. The American Journal of Surgical Pathology . 2009 (2)
  • 6George D Demetri,Allan T van Oosterom,Christopher R Garrett,Martin E Blackstein,Manisha H Shah,Jaap Verweij,Grant McArthur,Ian R Judson,Michael C Heinrich,Jeffrey A Morgan,Jayesh Desai,Christopher D Fletcher,Suzanne George,Carlo L Bello,Xin Huang,Charles M Baum,Paolo G Casali.Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial[J]. The Lancet . 2006 (9544)
  • 7Jeremy R. Parfitt,Cathy J. Streutker,Robert H. Riddell,David K. Driman.Gastrointestinal stromal tumors: A contemporary review[J]. Pathology - Research and Practice . 2006 (12)
  • 8John R. Zalcberg,Jaap Verweij,Paolo G. Casali,Axel Le Cesne,Peter Reichardt,Jean-Yves Blay,Marcus Schlemmer,Martine Van Glabbeke,Michelle Brown,Ian R. Judson.Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800<ce:hsp sp="0.25"/>mg after progression on 400<ce:hsp sp="0.25"/>mg[J]. European Journal of Cancer . 2005 (12)
  • 9Markku Miettinen,Leslie H Sobin,Jerzy Lasota.Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases With Long-term Follow-up[J].The American Journal of Surgical Pathology.2005(1)
  • 10Aurore Blesius,Philippe A Cassier,Fran?ois Bertucci,Jerome Fayette,Isabelle Ray-Coquard,Binh Bui,Antoine Adenis,Maria Rios,Didier Cupissol,David Pérol,Jean-Yves Blay,Axel Le Cesne.Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer . 2011

共引文献4

同被引文献38

引证文献5

二级引证文献13

实用癌症杂志
2015年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部